In This Section

Home / Learn / Cancer Types / Hematologic Malignancies

Hematologic Malignancies

Hematologic (blood) cancers, which impact the normal production and function of blood cells, often begin in bone marrow where stem cells develop into white blood cells, red blood cells, or platelets. These types of cancers occur when an uncontrolled growth of abnormal cells overtakes the development of normal blood cells, interfering with the regular functions of those cells. Hematologic cancers can be classified into three categories: leukemia, lymphoma, and multiple myeloma.

Developing quality improvement programs aimed at reducing health care disparities and improving the standard of care received by patients with hematologic cancers are key priorities in ACCC’s educational portfolio. Leverage our recent research and explore practical, actionable resources that you can implement in your cancer program today.

Acute Lymphocytic Leukemia (ALL)

Acute lymphocytic leukemia (ALL), also known as acute lymphoblastic leukemia, is a cancer of the blood and bone marrow.

Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (AML) is the most diagnosed blood cancer in adults. ACCC has initiated the education program to explore and address current barriers in care coordination and alternative therapy options.

Chronic Lymphocytic Leukemia (CLL)

Chronic lymphocytic leukemia is a cancer of the B-lymphocytes that may be found in the bone marrow, blood, lymph nodes, spleen and sometimes other organs.

Measurable Residual Disease (MRD) Testing

The MRD Implementation Roadmaps initiative will help multidisciplinary community cancer care teams better comprehend MRD testing by addressing barriers to incorporating the test into the treatment of ALL, CLL, and MM.

Multiple Myeloma (MM)

Multiple myeloma is the third most common hematologic cancer. However, compared to more frequently occurring cancers, multiple myeloma is relative rare and accounts for only 1.6 percent of diagnoses each year.

Myeloproliferative Neoplasms (MPNs)

Myeloproliferative neoplasms are blood cancers that carry a significant symptom burden and can develop aggressively. With no known cause and varying symptoms, myeloproliferative neoplasms can be difficult to diagnose and require meticulous treatment and follow-up care.

Reframing the Conversation: Effective Practices for Diffuse Large B-cell Lymphoma

Diffuse large B-cell lymphoma (DLBCL), is an aggressive disease affecting B-lymphocytes. There are many novel therapies and combination regimens currently being studied in clinical trials for the treatment of both newly diagnosed and relapsed/refractory DLBCL.

Relapsed/Refractory Mantle Cell Lymphoma (MCL)

Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin lymphoma (NHL). Access resources ACCC has developed to provide evidence-based guidelines on the management of MCL in the relapsed/refractory setting.

Returning to Practice in the Post-COVID-19 Era: Hematology Disease Education

Multiple myeloma is the third most common hematologic cancer. However, compared to more frequently occurring cancers, multiple myeloma is relative rare and accounts for only 1.6 percent of diagnoses each year.

Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) constitute a rare category of bone marrow disorders characterized by an accumulation of abnormal cells that can later progress to acute myeloid leukemia (AML).


On-Demand Webinars

Resource Libraries

Digital toolkits offer resources and tools to support the multidisciplinary cancer team in providing quality care for patients.



Real-world case studies enable cancer programs to reflect on current practices to reduce variations in care and positively impact patient outcomes.

Multiple Myeloma Dispensing Models: Effective Practices to Improve Care Delivery and the Patient Experience
Real-world case studies from University of Illinois Hospital and Health Services System, Miami Cancer Institute at Baptist Health South Florida, and John Theurer Cancer Center at Hackensack University Medical Center, analyze and summarize their existing dispensing models and practices in caring for patients with multiple myeloma.

Multidisciplinary Chronic Lymphocytic Leukemia Care: Quality Improvement Case Studies
The Outer Banks Hospital, Billings Clinic Cancer Center, and the Ohio State University Comprehensive Cancer Center participated in quality improvement workshops in 2020.

Multidisciplinary Chronic Lymphocytic Leukemia Care: Models of Effective Care Delivery
To understand how patient-focused multidisciplinary care is effectively delivered across care settings, ACCC conducted site-visit focus groups at Self Regional Healthcare Cancer Center, The University of Kansas Cancer Center, and Sunrise Hospital and Medical Center.

Multidisciplinary Multiple Myeloma Care: Models of Effective Care Delivery
ACCC spoke with care team members at Yuma Regional Medical Center Cancer Center, John Theurer Cancer Center at Hackensack University Medical Center, and Moffitt Cancer Center to better understand how cancer centers are incorporating a multidisciplinary approach to diagnosing and managing patients with multiple myeloma.

From the ACCCBuzz Blog

From Oncology Issues